American Healthcare REIT, Inc. (AHR) stock
Close on Nov 18, 2026Market cap $12.76BP/E 86.1Yield 1.71%
Earnings
American Healthcare REIT's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of American Healthcare REIT's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 25, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026after the close | $742.15M | +29.5% | $0.14 | $0.58 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026after the close | $674.25M | +24.3% | $0.16 | $0.54 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026after the close | $650.77M | +20.4% | $0.13 | $0.50 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 26, 2026after the close | – | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025after the close | $572.94M | – | $0.33 | $0.44 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025after the close | $542.50M | +7.5% | $0.06 | $0.42 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025after the close | $540.60M | +8.2% | -$0.04 | $0.38 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024after the close | – | – | -$0.03 | $0.36 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 5, 2024after the close | $504.58M | – | $0.01 | $0.33 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 13, 2024after the close | $499.53M | – | -$0.04 | $0.30 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 21, 2024after the close | $482.58M | – | -$0.42 | $0.38 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
American Healthcare REIT's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| ISHC Segment-Level SS NOI Growthnon-GAAP | FY2026 | +13% – +16% | – | Raised | Aug 6, 2026 |
| Total Portfolio SS NOI Growthnon-GAAP | FY2026 | +12% – +14% | – | New | Nov 5, 2026 |
| Net income per diluted shareGAAP | FY2026 | $0.59 – $0.62 | – | New | Nov 5, 2026 |
| Net income per diluted shareGAAP | FY2026 | $0.54 – $0.58 | $0.51 – $0.57 | Raised | Aug 6, 2026 |
| NFFO per diluted sharenon-GAAP | FY2026 | $2.23 – $2.26 | – | New | Nov 5, 2026 |
| NFFO per diluted sharenon-GAAP | FY2026 | $2.15 – $2.19 | $1.93 – $1.99 | Raised | Aug 6, 2026 |
| NAREIT FFO attributable to common stockholdersnon-GAAP | FY2026 | $369.20M – $380.48M | – | New | May 7, 2026 |
| NAREIT FFO per diluted sharenon-GAAP | FY2026 | $2.13 – $2.16 | – | New | Nov 5, 2026 |
| NAREIT FFO per diluted sharenon-GAAP | FY2026 | $2.04 – $2.08 | – | New | Aug 6, 2026 |
| Net income attributable to common stockholdersGAAP | FY2026 | $97.80M – $109.08M | – | New | May 7, 2026 |
| Normalized FFO attributable to common stockholdersnon-GAAP | FY2026 | $388.19M – $399.47M | – | Raised | May 7, 2026 |
| Segment-Level SS NOI Growth: ISHCnon-GAAP | FY2026 | +11% – +15% | – | Raised | May 7, 2026 |
| Segment-Level SS NOI Growth: Outpatient Medicalnon-GAAP | FY2026 | 0% – +2% | – | Lowered | May 7, 2026 |
| Segment-Level SS NOI Growth: SHOPnon-GAAP | FY2026 | +15% – +19% | – | Raised | May 7, 2026 |
| Segment-Level SS NOI Growth: Triple-Net Leased Propertiesnon-GAAP | FY2026 | +2% – +3% | – | Raised | May 7, 2026 |
| Total Portfolio SS NOI Growthnon-GAAP | FY2026 | +9% – +12% | – | New | May 7, 2026 |
Guidance history
Every forecast American Healthcare REIT put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | NFFO per diluted share | FY2026 | $2.23 – $2.26 | New |
| Nov 5, 2026 | Net income per diluted share | FY2026 | $0.59 – $0.62 | New |
| Nov 5, 2026 | Total Portfolio SS NOI Growth | FY2026 | +12% – +14% | New |
| Nov 5, 2026 | NAREIT FFO per diluted share | FY2026 | $2.13 – $2.16 | New |
| Aug 6, 2026 | ISHC Segment-Level SS NOI Growth | FY2026 | +13% – +16% | Raised |
| Aug 6, 2026 | Triple-Net Leased Properties Segment-Level SS NOI Growth | FY2026 | +2% – +3% | Raised |
| Aug 6, 2026 | SHOP Segment-Level SS NOI Growth | FY2026 | +18% – +21% | Raised |
| Aug 6, 2026 | Total Portfolio SS NOI Growth | FY2026 | +11% – +13% | New |
| Aug 6, 2026 | Outpatient Medical Segment-Level SS NOI Growth | FY2026 | 0% – +1% | Lowered |
| Aug 6, 2026 | NFFO per diluted share | FY2026 | $2.15 – $2.19 | Raised |
| Aug 6, 2026 | Net income per diluted share | FY2026 | $0.54 – $0.58 | Raised |
| Aug 6, 2026 | NAREIT FFO per diluted share | FY2026 | $2.04 – $2.08 | New |
| May 7, 2026 | NAREIT FFO per diluted share | FY2026 | $1.93 – $1.99 | New |
| May 7, 2026 | NFFO per diluted share | FY2026 | $2.03 – $2.09 | Raised |
| May 7, 2026 | Net income per diluted share | FY2026 | $0.51 – $0.57 | New |
| May 7, 2026 | Segment-Level SS NOI Growth: SHOP | FY2026 | +15% – +19% | Raised |
| May 7, 2026 | Normalized FFO attributable to common stockholders | FY2026 | $388.19M – $399.47M | Raised |
| May 7, 2026 | NAREIT FFO attributable to common stockholders | FY2026 | $369.20M – $380.48M | New |
| May 7, 2026 | Net income attributable to common stockholders | FY2026 | $97.80M – $109.08M | New |
| May 7, 2026 | Segment-Level SS NOI Growth: Triple-Net Leased Properties | FY2026 | +2% – +3% | Raised |
| May 7, 2026 | Segment-Level SS NOI Growth: Outpatient Medical | FY2026 | 0% – +2% | Lowered |
| May 7, 2026 | Segment-Level SS NOI Growth: ISHC | FY2026 | +11% – +15% | Raised |
| May 7, 2026 | Total Portfolio SS NOI Growth | FY2026 | +9% – +12% | New |
| Nov 6, 2025 | Segment-Level Same-Store NOI growth / (decline): Triple-Net Leased Properties | FY2025 | -0.3% – +0.3% | Lowered |
| Nov 6, 2025 | Total Portfolio Same-Store NOI growth | FY2025 | +13% – +15% | New |
| Nov 6, 2025 | Segment-Level Same-Store NOI growth / (decline): ISHC | FY2025 | +17% – +20% | Raised |
| Nov 6, 2025 | Segment-Level Same-Store NOI growth / (decline): Outpatient Medical | FY2025 | +2% – +2.4% | Lowered |
| Nov 6, 2025 | Segment-Level Same-Store NOI growth / (decline): SHOP | FY2025 | +24% – +26% | Raised |
| Nov 6, 2025 | Normalized FFO per common share — diluted | FY2025 | $1.69 – $1.72 | New |
| Nov 6, 2025 | Net income per common share — diluted | FY2025 | $0.47 – $0.50 | New |
| Nov 6, 2025 | NAREIT FFO per common share — diluted | FY2025 | $1.71 – $1.74 | New |
| Nov 6, 2025 | Net income attributable to common stockholders | FY2025 | $78.00M – $83.00M | New |
| Nov 6, 2025 | NAREIT FFO attributable to common stockholders | FY2025 | $283.50M – $288.50M | New |
| Nov 6, 2025 | Normalized FFO attributable to common stockholders | FY2025 | $280.10M – $285.10M | Lowered |
| Aug 7, 2025 | Segment-Level SS NOI Growth / (Decline): Triple-Net Leased Properties | FY2025 | -0.8% – -0.3% | Lowered |
| Aug 7, 2025 | Segment-Level SS NOI Growth / (Decline): Outpatient Medical | FY2025 | +1% – +1.5% | Lowered |
| Aug 7, 2025 | Segment-Level SS NOI Growth / (Decline): ISHC | FY2025 | +15% – +19% | Raised |
| Aug 7, 2025 | Total Portfolio SS NOI Growth | FY2025 | +11% – +14% | New |
| Aug 7, 2025 | Segment-Level SS NOI Growth / (Decline): SHOP | FY2025 | +20% – +24% | Raised |
| Aug 7, 2025 | NFFO per diluted share | FY2025 | $1.64 – $1.68 | Raised |
| Aug 7, 2025 | Net income per diluted share | FY2025 | $0.33 – $0.37 | Raised |
| Aug 7, 2025 | NAREIT FFO per diluted share | FY2025 | $1.57 – $1.61 | Raised |
| May 8, 2025 | Normalized FFO per common share — diluted | FY2025 | $1.58 – $1.64 | New |
| May 8, 2025 | Net income per common share — diluted | FY2025 | $0.29 – $0.35 | New |
| May 8, 2025 | ISHC Same-Store NOI growth | FY2025 | +12% – +16% | Raised |
| May 8, 2025 | SHOP Same-Store NOI growth | FY2025 | +20% – +24% | Raised |
| May 8, 2025 | Outpatient Medical Same-Store NOI growth / (decline) | FY2025 | -1% – +1% | Lowered |
| May 8, 2025 | Total Portfolio Same-Store NOI growth | FY2025 | +9% – +13% | New |
| May 8, 2025 | Triple-Net Leased Properties Same-Store NOI growth / (decline) | FY2025 | -1.5% – -0.5% | Lowered |
| May 8, 2025 | NAREIT FFO per common share — diluted | FY2025 | $1.49 – $1.55 | New |
| Nov 12, 2024 | Total portfolio Same-Store NOI growth | FY2024 | +15% – +17% | Raised |
| Nov 12, 2024 | Normalized FFO per common share — diluted | FY2024 | $1.40 – $1.43 | Raised |
| Aug 5, 2024 | Segment-Level Same-Store NOI growth SHOP | FY2024 | +45% – +50% | Raised |
| Aug 5, 2024 | Segment-Level Same-Store NOI growth ISHC | FY2024 | +18% – +20% | Raised |
| Aug 5, 2024 | Total Portfolio Same-Store NOI growth | FY2024 | +12% – +14% | New |
| Aug 5, 2024 | Segment-Level Same-Store NOI growth Triple-Net Leased Properties | FY2024 | +1% – +3% | Lowered |
| Aug 5, 2024 | Segment-Level Same-Store NOI growth OM | FY2024 | -0.5% – 0% | Lowered |
| Aug 5, 2024 | Normalized FFO per common share — diluted | FY2024 | $1.23 – $1.27 | Raised |
| Aug 5, 2024 | NAREIT FFO per common share — diluted | FY2024 | $1.17 – $1.22 | Lowered |
| Aug 5, 2024 | Net (loss) income per common share — diluted | FY2024 | -$0.07 – -$0.02 | Lowered |
| May 13, 2024 | Normalized FFO per common share | FY2024 | $1.18 – $1.24 | New |
| May 13, 2024 | Net (loss) income per common share | FY2024 | -$0.03 – $0.03 | New |
| May 13, 2024 | Total Portfolio Same-Store NOI growth | FY2024 | +5% – +7% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases American Healthcare REIT filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Update
- Results
- Results
- Update
- Update
- Results
- Results
- Update
- Results
- Results
- Update
See a number that looks wrong?